Latest Regulatory Risks News

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.

Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.

DigitalX Limited reveals a robust A$101 million treasury portfolio dominated by Bitcoin holdings and a significant cash increase from Solana sales, underpinning its ambitious target of accumulating 2,100 Bitcoins by 2027.

COG Financial Services is raising A$20 million through an institutional placement to acquire an additional 14.08% stake in Fleet Network, increasing its ownership to over 92%. This move is expected to immediately enhance earnings per share and support COG’s strategic growth in novated leasing and salary packaging.

Netwealth Group Limited has reported a landmark quarter with total Funds Under Administration soaring to $120.8 billion, driven by record first-quarter net flows of $4.1 billion and strategic service expansions.

Predictive Discovery Limited and Robex Resources Inc. have agreed to merge, creating a mid-tier gold producer in West Africa with combined output expected to exceed 400,000 ounces annually by 2029.

Felix Gold Limited has been found in breach of ASX continuous disclosure rules after delaying the announcement of a U.S. federal site visit to its Alaska antimony project, prompting an internal review of its disclosure policies.

InFocus Group Holdings has launched a dedicated iGaming business unit, aiming to capitalize on the booming $95 billion online gaming industry with key contracts and digital asset integration.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Yancoal Australia Ltd reported a sharp 61% drop in net profit for the first half of 2025 amid falling coal prices and supply chain disruptions, despite a 15% rise in production. The company declared a fully franked interim dividend and is advancing strategic acquisitions and sustainability initiatives.